Waregem (Belgium), 24 August 2009 - In accordance with the stipulations of article 29 of the Act of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus informs that it has received on 21 August a notification of shareholding from KBC Asset Management NV.
Based on the denominator of 31,195,121 (total number of voting rights) and the relevant notifications, the structure of the shareholding of Arseus is as follows:
|
|
number of voting rights |
% of total |
|
Fortis Investment Management SA |
2,756,357 |
8.84% |
|
Omega Pharma NV* |
7,500,000 |
24.04% |
|
Couckinvest NV / Coucke* |
3,858,080 |
12.37% |
|
Arseus NV (treasury shares) |
973,915 |
3.12% |
|
KBC Asset Management NV |
958,749 |
3.07% |
|
Public |
15,148,020 |
48.56% |
* related parties as specified in the Belgian Company Code
The original notification forms are also available on the corporate website (www.arseus.com).
This is a translation of the Dutch press release; the Dutch press release prevails.
Please open the link below for the full press release:
